Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Sarepta Therapeutics Inc (NASDAQ:SRPT)

30.01
Delayed Data
As of May 26
 -0.84 / -2.72%
Today’s Change
14.83
Today|||52-Week Range
63.73
+9.41%
Year-to-Date
Biotech Needs a Shot in the Arm
May 26 / TheStreet.com - Paid Partner Content
 

Today’s Trading

Previous close30.85
Today’s open30.76
Day’s range29.40 - 30.89
Volume2,128,921
Average volume (3 months)2,195,785
Market cap$1.6B
Dividend yield--
Data as of 3:59pm ET, 05/26/2017

Growth & Valuation

Earnings growth (last year)-5.58%
Earnings growth (this year)+86.42%
Earnings growth (next 5 years)+0.37%
Revenue growth (last year)+332.64%
P/E ratioNM
Price/Sales246.40
Price/Book4.88

Competitors

 Today’s
change
Today’s
% change
HZNPHorizon Pharma PLC+0.23+2.31%
CBMCambrex Corp0.000.00%
LXRXLexicon Pharmaceutic...-0.15-1.03%
SUPNSupernus Pharmaceuti...+1.60+4.69%
Data as of 4:02pm ET, 05/26/2017

Financials

Next reporting dateAugust 10, 2017
EPS forecast (this quarter)-$0.89
Annual revenue (last year)$5.4M
Annual profit (last year)-$267.3M
Net profit margin-4,930.18%

Profile

Sector
Health Technology
Industry
Biotechnology
President &
Director
Edward M. Kaye
Executive VP, Chief Financial &
Business Officer
Sandesh Mahatme
Corporate headquarters
Cambridge, Massachusetts

Forecasts